Madrigal Pharmaceuticals ...

NASDAQ: MDGL · Real-Time Price · USD
365.51
-5.86 (-1.58%)
At close: Aug 15, 2025, 12:40 PM

Madrigal Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-14.09 -11.57 -16.84 -5.79
PEG Ratio
-1.47 -0.72 -0.95 -0.49
PS Ratio
36.44 n/a n/a n/a
PB Ratio
8.70 10.67 25.20 7.14
P/FCF Ratio
-14.36 -13.28 -22.1 -7.61
P/OCF Ratio
-14.41 -13.34 -22.12 -7.62
OCF/S Ratio
-2.53 n/a n/a n/a
Debt / Equity Ratio
0.16 0.29 0.25 0.00
Quick Ratio
5.90 5.38 3.12 3.54
Current Ratio
6.10 5.38 3.12 3.54
Asset Turnover
0.17 n/a n/a n/a
Interest Coverage
-33.94 -29.93 -74.06 n/a
Return on Equity
-0.62 -0.92 -1.5 -1.23
Return on Assets
-0.45 -0.58 -0.81 -0.88
Return on Invested Capital
-0.57 -0.73 -1.19 -1.23
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.97 n/a n/a n/a
Net Profit Margin
-2.59 n/a n/a n/a
Pretax Profit Margin
-2.59 n/a n/a n/a
Operating Profit Margin
-2.76 n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-2.5 n/a n/a n/a